Celebrating the successes of UK translation – our 2019 annual reception

Melanie Lee, LifeArc CEO acknowledges the success of the life sciences and translational research sectors in the UK

Patients with ultra-rare bone marrow disease set to benefit from £1.15m grant from LifeArc and The Aplastic Anaemia Trust

A research grant to investigate the potential of a novel type of “personalised cellular therapy” to reverse the ultra-rare condition, aplastic anaemia

LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases

Investment to allow Caldan to translate work on free fatty acid receptors initiated in their laboratories

Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies

The agreement will enable LifeArc to enhance our antibody drug discovery capabilities

LifeArc invests £1.5 million in Ducentis BioTherapeutics

LifeArc’s Seed Fund has invested £1.5 million in Ducentis BioTherapeutics to develop novel drug therapies for inflammatory and autoimmune disease

LifeArc monetises Keytruda® royalty interests to fund further research and investment

LifeArc receives US$1.3bn for a portion of royalty interests in Keytruda (pembrolizumab), making us one of the UK’s leading medical research charities by size of investment assets

Medicines Discovery Catapult and LifeArc launch strategic R&D partnership in biomarker discovery and proteomics technology

Three-year partnership to fund clinical application of biomarker strategies to help progress novel drug candidates to clinical evaluation stage

LifeArc and The University of Kent collaborate to develop potential pain medicines

Three-year programme will focus on ion channel drug discovery, to evaluate if small molecule modulators, optimised as part of the research, could show efficacy in treating chronic pain.

LifeArc licenses lead stage molecules to Daiichi Sankyo

London UK, April 16, 2019: LifeArc, one of the UK’s leading medical research charities, has signed a…